Zinc-aluminium ointment for patients with faecal incontinence

Zinc-aluminium ointment for patients with faecal incontinence: a double blind randomised trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN05200282

Enrollment

Registered

2010-12-08

Start date

2010-03-10

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Faecal incontinence Digestive System Faecal incontinence

Interventions

Treatment group: Topical application of ointment in the perianal region for 4 weeks. Ointment consists of Aluminum Sulphate (0.5%), Zinc Sulphate (0.1%), Benzocaine (0.05%), Clorhexidine (0.09%) and

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Female 2. Aged 18 years or older 3. Consulted the outpatient clinic in the Colorectal unit of Pontificia Universidad Catolica de Chile 4. Faecal incontinence 5. Wexner Score greater than or equal to 7 6. Minima sphincter disruption in anal endosonography 7. Signed informed consent

Exclusion criteria

Exclusion criteria: 1. Male 2. Sphincter disruption greater than 50%

Design outcomes

Primary

Measure	Time frame
Wexner Score, measured at baseline and 4 weeks	—

Secondary

Measure	Time frame
Faecal Incontinence Quality of Life (FIQL) score, measured at baseline and 4 weeks	—

Countries

Chile

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026